Testosterone Cream vs Gel for Women: What's Actually Different

For women in the U.S., "cream vs gel" is rarely a choice between two FDA-approved medicines, because none are approved for women. In real life it's a compounded cream made at a female strength (easier to dose, but not FDA-approved) versus an FDA-approved men's gel used off-label at roughly one-tenth the male dose (commercially manufactured and standardized, but built for men). Cream usually wins on dosing ease; gel wins on manufacturing standards.

No. In the U.S., no testosterone product — cream, gel, patch, pill, pellet, or shot — is FDA-approved specifically for women. VA clinical guidance says it plainly: there are no FDA-approved testosterone products indicated for use in women in the U.S. This one fact reshapes the whole cream-vs-gel question, and it's the piece most pages leave out.

Two things follow from it, and both matter for your choice.

First, testosterone is a Schedule III controlled substance. Refills are capped by federal law, you can't stockpile it, and you'll need periodic visits to renew a prescription. Any website that treats testosterone like a one-click refill isn't doing it right.

Second, "FDA-approved gel" and "compounded cream" are two different regulatory categories. The gels that are FDA-approved (AndroGel, Testim, and generics) are approved for men with low testosterone. When a clinician gives one to a woman, that's off-label use — an approved drug at a smaller dose than it's labeled for. A compounded cream is different: it's not an FDA-approved drug at all. A compounding pharmacy makes it to order; the FDA doesn't review it for safety, effectiveness, or quality before it's sold.

There is a testosterone cream designed for women — AndroFeme 1% — but it's approved in some countries abroad (including Australia and New Zealand), not by the FDA, and it isn't sold through normal U.S. pharmacy channels. The FDA turned down a testosterone patch for women back in 2004 over a lack of long-term safety data. That gap is real — and it's why monitoring matters so much with either form you choose.

For a woman, a testosterone "gel" almost always means an FDA-approved men's gel used off-label at a low dose. Its strength is that it's standardized: every tube or packet holds a known, consistent amount of testosterone, made under strict, FDA-regulated manufacturing rules. Its weakness for women is the flip side — it's packaged in male-sized doses, so your dose is a small slice you have to measure yourself.

Women in studies used about one-tenth of the men's dose. VA guidance spells it out for one common product: a 1% testosterone gel in a 5-gram tube holds 50 mg of testosterone; a woman's starting dose is 5 mg (0.5 mL) — one-tenth of the tube — bumping to 10 mg only if needed. That's why clinicians often hand you a small syringe to measure it, and why blood-level checks matter so much.

Gel dose math is product-specific. Different gels have different strengths and dispensers, so "one-tenth" doesn't convert the same way for all of them.

For a woman, a testosterone "cream" is usually a compounded product — custom-mixed by a compounding pharmacy from your clinician's prescription. Its biggest edge is exactly what the gel struggles with: it can be made at a female strength, so the small dose women need is easier to apply the same way every day. Many women also find a cream's moisturizing base gentler than an alcohol gel.

The trade-off is regulation. A compounded cream is not an FDA-approved drug, and the FDA does not verify compounded drugs for strength, purity, or quality before they're sold — so quality leans heavily on the pharmacy that makes it. That's not a reason to rule it out. It's a reason to use one that's prescribed and monitored by a real clinician, from a reputable pharmacy — not ordered from an unvetted website. "Compounded" does not mean "FDA-approved," "generic," "more natural," or automatically safe. It means made-to-order and not FDA-reviewed.

A few smart questions turn "trust me" into "show me." Before you fill a compounded cream, ask: which pharmacy will make it, is it a state-licensed pharmacy, what's the exact strength and dose per click or pump, what's the expiration date, and how do I report a problem?

For women, cream goes on a small patch of skin your prescriber specifies — commonly the thigh (Midi directs its cream to the inner thigh; VA guidance lists the back of the calf, upper outer thigh, or buttock for off-label gel), rotating the spot.

Cream, in one line: easier to dose at a true female strength and often gentler on skin — but made-to-order, so oversight and the pharmacy's quality carry the load.

Cream is usually easier to dose because it's mixed at a female strength; a men's gel forces you to measure a small fraction of a male dose. Either way, the goal is the same: keep your testosterone in the normal premenopausal range — not above it. That's why a good clinician orders baseline and follow-up bloodwork and adjusts your dose from there.

Here's what solid monitoring looks like, straight from VA clinical guidance — and it's the same whether you use cream or gel:

• Before you start: baseline labs — total testosterone, SHBG (sex hormone-binding globulin), liver function tests, and a lipid (cholesterol) panel.
• Reality check: your testosterone level doesn't diagnose low libido and doesn't predict whether treatment will work. Levels are used to keep you in the normal range — not to "prove" you need testosterone. Be skeptical of any pitch that says a single lab number means you're deficient and should buy.
• After you start: recheck total testosterone 3 to 6 weeks after starting and after any dose change. Once stable, check every 4 to 6 months.
• The honest timeline: most women judge the effect over about 6 to 8 weeks. If there's no meaningful improvement by 6 months, guidance says stop — it's not working for you.

Most side effects come down to your dose and how much testosterone you absorb — not whether it's called "cream" or "gel." At proper low (physiologic) doses, the common effects are acne and a bit more facial or body hair. Push levels too high and the risks grow — oily skin, unwanted hair, scalp hair thinning, mood changes, and, at clearly excessive levels, deeper voice or other masculinizing changes. This is exactly why staying in the normal female range, with monitoring, matters more than the form you pick.

Keep an eye on: acne or oily skin, new facial or body hair, hair growth right at the application spot, scalp hair shedding, mood shifts, any voice change, and any sign that medicine rubbed off on someone else.

Two things belong in your eligibility conversation, and honest pages should say so. First, blood pressure. In 2025 the FDA updated the labeling on FDA-approved testosterone products: it removed an older boxed warning about heart-attack and stroke risk and added a warning that testosterone can raise blood pressure. So your blood pressure and heart health belong in the discussion. Second, the long view. The trials behind testosterone for women are reassuring but limited: many studies excluded higher-risk patients, and long-term safety data (especially heart and breast) are still limited.

Transfer risk is the one place cream vs gel gets personal, and it applies to both. Testosterone on your skin can rub onto other people or pets through skin-to-skin contact until it's absorbed or washed off. The dose women use is small and goes on a covered area, so the risk is lower than it is for men — but it's real, and it matters most around children and anyone who's pregnant.

In women, testosterone has strong evidence for exactly one thing — sexual desire — and weak or no evidence for the rest. The 2019 Global Consensus Statement (endorsed by The Menopause Society, the Endocrine Society, and international groups) and the 2021 ISSWSH guideline both support testosterone for one use: hypoactive sexual desire disorder (HSDD) in postmenopausal women. HSDD means low or absent sexual desire that genuinely distresses you and isn't better explained by something else.

How much does it help? A 2019 analysis pooling 8,480 women across 36 randomized trials found testosterone gave women with HSDD, on average, about one more satisfying sexual event per month, plus improvements in desire, arousal, orgasm, and pleasure, and less distress about sex. Real and meaningful for many women — and modest.

Compounded testosterone cream is what many menopause specialists actually prescribe for women — but it carries a different risk profile than an FDA-approved product, and the leading guidelines still prefer an approved product where one can be dosed for you.

The case against compounded, stated plainly: the 2019 Global Consensus recommended against compounded testosterone, and the 2021 ISSWSH guidance echoes it. The concern is concrete — the FDA doesn't verify compounded drugs for strength, purity, or quality before they're sold.

Now the part that decides it in the real world: there's no FDA-approved testosterone for women in the U.S. at all, and the FDA-approved men's gels are dosed for men — which makes precise low-dose female use genuinely awkward. That gap is exactly why many menopause specialists use a compounded cream at a female strength, paired with blood-level checks, as a practical way to keep a woman in the normal range. The risk with testosterone for women isn't only the word "compounded" — it's an unverified formulation combined with guessing the dose, skipping labs, or chasing levels above the female range. A compounded cream from a specialist who orders your labs, starts you low, and rechecks your levels is a completely different situation from a cream ordered off a random website with no monitoring.

So the real question isn't "cream or gel?" It's what's the oversight around it?

• If FDA manufacturing standards are your non-negotiable, ask your prescriber about an FDA-approved gel dosed down for you — the guideline-preferred route.
• If easier, consistent female dosing matters more, a compounded cream from a reputable pharmacy, prescribed and monitored by a menopause clinician, is a legitimate path — as long as the monitoring is real.
• Either way, steer clear of pellets, shots, unmonitored online sources, and anyone who skips baseline labs or promises benefits beyond libido.

Plan to pay out-of-pocket for the medication, whichever form you choose — the bigger cost swing is your visits and labs, not cream vs gel. Compounded creams are almost always cash-pay, and an FDA-approved men's gel used off-label for a woman often isn't covered either. What insurance can cover is the visit with an in-network clinician.

For real, published numbers, here's what one insurance-accepting provider lists. Treat these as provider-stated figures, not a shopped-around pharmacy quote:

The path is the same no matter the form: a visit with a clinician who can prescribe, baseline labs, a low starting dose, and follow-up monitoring. Testosterone is a controlled substance and staying in the normal range is the entire point. What differs is which provider will actually do it, and do it well.

What to look for in a provider:

• They prescribe testosterone for women in your state.
• They require labs — baseline testosterone and SHBG, with follow-up checks. Skipping labs is a red flag.
• They start low and monitor, aiming for the normal premenopausal range, and don't push pellets or shots.
• They keep FDA-approved and compounded straight and tell you which you're getting and why.
• They respect the controlled-substance rules — real visits, not instant refills.

Low desire in midlife often isn't a testosterone problem at all — and if it isn't, testosterone won't fix it. Here's how to think about it:

• If sex hurts or you're dry, that's usually genitourinary syndrome of menopause (GSM) — thinning, drier tissues from low estrogen. The first-line fixes are local vaginal estrogen or vaginal DHEA, plus non-hormonal moisturizers and lubricants. Testosterone won't solve dryness.
• If the bigger problem is hot flashes, night sweats, or wrecked sleep, that points to systemic hormone therapy (if you're a candidate) or non-hormonal options — not testosterone.
• If desire itself is the issue, know there are now FDA-approved, non-hormonal medicines for HSDD — and unlike testosterone, they are FDA-approved for this. Addyi (flibanserin) was expanded in December 2025 to women under 65 (including postmenopausal women), and Vyleesi (bremelanotide) is approved for premenopausal women. They carry their own risks and rules — but worth asking a clinician about.
• If it's distressing low desire after menopause, and other causes are handled — that's the lane where testosterone (cream or gel) actually fits.

The point isn't to talk you out of testosterone. It's to make sure you're solving the right problem.

Walk into your consult knowing what you want, and "cream or gel?" turns into a quick, confident decision with your prescriber. There's no universally correct answer — there's the one that fitsyour priorities. Run these and you'll know which way you lean, and you'll spot a sketchy provider fast.